Talphera (TLPH) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Talphera (TLPH) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 180.02 Bn | 176.84 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 131.54 Bn | 123.69 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.96 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 60.23 Bn | 55.04 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 53.85 Bn | 48.72 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.88 Bn | 30.59 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Talphera | 93.28 Mn | 93.28 Mn | - | 2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.67 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 3.72 Mn |
| Jun 30, 2022 | 3.96 Mn |
| Mar 31, 2022 | 7.34 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Sep 30, 2021 | 8.64 Mn |
| Jun 30, 2021 | 8.69 Mn |